Michael Barbella, Managing Editor03.24.23
Tidepool has appointed John Lister as chief operating officer.
Lister has more than 15 years of diabetes industry experience serving in various executive roles, most notably at Dexcom, where, over 12 years, he led the legal and human resources groups, and later launched Dexcom’s international business, primarily from Europe. During his tenure there, Lister served on Dexcom’s executive management team, which led the launch of six generations of CGM in more than 35 countries. In addition, Lister has more recently advised several diabetes companies on strategic matters, and previously served as a corporate attorney for Fenwick & West, advising emerging growth technology companies.
Lister earned his J.D. from the University of San Francisco.
“John’s inclusive leadership approach is ideally matched to drive Tidepool through this critical inflection point, as we prepare for the next generation of products that will have an even bigger impact on our community,” Tidepool Founder/CEO Howard Look said. “His decades of experience in scaling businesses, high performance team development and deep knowledge and understanding of the industry will give us a solid foundation for this next phase of Tidepool’s growth.”
As the diabetes device industry continues to innovate, Tidepool has taken a role in helping create and operate systems that allow for patient and clinician choice. Tidepool received U.S. Food and Drug Administration clearance in late January for Tidepool Loop, an iPhone-controlled interoperable automated glycemic controller (iAGC) for type 1 diabetes management. Tidepool is also filling the gap for unmet clinician needs with Tidepool+, its clinic offering. Tidepool+ provides workflow efficiencies leading to improved clinician and patient experiences with additional product features that lean into Tidepool’s expertise in intuitive user-design.
“With its technologies and strong team, I believe Tidepool is positioned to enable insight and action that can help a very large number of patients, clinicians and caregivers,” Lister stated. “I am excited about the opportunities to make lasting change in the diabetes community and look forward to working closely with the team to scale the impact of all the work being done at Tidepool.”
Tidepool is an innovator in diabetes software on a mission to make diabetes data more accessible, actionable, and meaningful for people with diabetes, their care teams, and researchers. Founded in 2013, Tidepool hosts a suite of software tools for people with diabetes and the clinics that serve them, including Tidepool Web, Tidepool Mobile, Tidepool Uploader, and soon Tidepool Loop. Tidepool is a registered 501(c)3 nonprofit organization.
Lister has more than 15 years of diabetes industry experience serving in various executive roles, most notably at Dexcom, where, over 12 years, he led the legal and human resources groups, and later launched Dexcom’s international business, primarily from Europe. During his tenure there, Lister served on Dexcom’s executive management team, which led the launch of six generations of CGM in more than 35 countries. In addition, Lister has more recently advised several diabetes companies on strategic matters, and previously served as a corporate attorney for Fenwick & West, advising emerging growth technology companies.
Lister earned his J.D. from the University of San Francisco.
“John’s inclusive leadership approach is ideally matched to drive Tidepool through this critical inflection point, as we prepare for the next generation of products that will have an even bigger impact on our community,” Tidepool Founder/CEO Howard Look said. “His decades of experience in scaling businesses, high performance team development and deep knowledge and understanding of the industry will give us a solid foundation for this next phase of Tidepool’s growth.”
As the diabetes device industry continues to innovate, Tidepool has taken a role in helping create and operate systems that allow for patient and clinician choice. Tidepool received U.S. Food and Drug Administration clearance in late January for Tidepool Loop, an iPhone-controlled interoperable automated glycemic controller (iAGC) for type 1 diabetes management. Tidepool is also filling the gap for unmet clinician needs with Tidepool+, its clinic offering. Tidepool+ provides workflow efficiencies leading to improved clinician and patient experiences with additional product features that lean into Tidepool’s expertise in intuitive user-design.
“With its technologies and strong team, I believe Tidepool is positioned to enable insight and action that can help a very large number of patients, clinicians and caregivers,” Lister stated. “I am excited about the opportunities to make lasting change in the diabetes community and look forward to working closely with the team to scale the impact of all the work being done at Tidepool.”
Tidepool is an innovator in diabetes software on a mission to make diabetes data more accessible, actionable, and meaningful for people with diabetes, their care teams, and researchers. Founded in 2013, Tidepool hosts a suite of software tools for people with diabetes and the clinics that serve them, including Tidepool Web, Tidepool Mobile, Tidepool Uploader, and soon Tidepool Loop. Tidepool is a registered 501(c)3 nonprofit organization.